Enrich is the leader in biotech and pharmaceutical portfolio management software, with more than half of the top 10 life sciences companies among our clients. Why? We understand how to value and manage portfolios of high risk, high investment assets, and help your organization improve its portfolio prioritization capabilities so you’re making the right trade-offs for short- and long-term success. When it comes to pharma portfolio management, no software is more trusted than EAP.
With resources more constrained than ever, our resource planning software enables you to forecast FTE demand from ongoing and future clinical trials, perform a gap analysis to determine which resources will be the bottlenecks, and conduct scenario analysis to understand which projects should be delayed or accelerated to alleviate the bottlenecks and maximize value.
Our sales planning software is designed for today’s global life sciences firms. EAP’s web interface is perfect for capturing regional forecasts from sales teams around the world, allowing them to be easily aggregated and reconciled with global forecasts. The impact of market events, such as competitor branded or biosimilar launches, can be modeled–with or without incorporating the probability of occurrence–and layered onto the forecasts.